Primary care physicians will receive training to improve their knowledge and skills in the management of the asthmatic patient.

-50% of patients with asthma are undiagnosed, so it is a condition that is underdiagnosed and infratratada

– it is estimated that up to 60-70% of asthmatics suffer from poor control of disease according to the recommendations of the Global Initiative for Asthma (GINA) or the Spanish Guide for the management of asthma (GEMA)

– according to a study on knowledge and monitoring asthma by Spanish health workers, only 19% of physicians properly classified a case of asthma, AP doctors implanted only 8% of people with asthma education programs, and there is a poor prescription of inhaled corticosteroids

-the programme of Integral formation in asthmaClassroom 60 clinical sessions at the health centre is nationwide and is aimed to disseminate and implement guidelines and aims to involve about 10,000 primary care physicians to improve the continuous and comprehensive care of the asthmatic patient

Madrid, April of 2013- asthma is a public health problem posed by more than three million euros to the the national health system (SNS) year by absenteeism from work and school which causes and for being one of the diseases that most visits in the field of primary care (AP).

With the aim of improving the knowledge and skills of the family physicians in the management of the asthmatic patient, SEMERGEN organized nationally during the 2013, in collaboration with the laboratories Chiesi, Integral formation in asthma, 60 classroom program ’. Sessions clinics at the health center. These educational programs are designed to disseminate and implement guidelines for asthma in centers of health aiming to reach about 10,000 primary care physicians to improve knowledge and skills in the continuous and comprehensive care of the asthmatic patient.

Today, 50% of asthma patients are undiagnosed, for what it is a pathology underdiagnosed and infratratada, ensure Pulmonology experts.

This situation we must add that it gets only 19% of physicians classify precisely a case of asthma, doctors of AP only implant education programs for patients in 8% of asthmatics, at the time identified inadequate prescription of inhaled corticosteroids, according to a study on knowledge and monitoring of asthma by Spanish health professionals ”, explains Dr. José Antonio Quintano, Coordinator of the Working Group of SEMERGEN respiratory.

The methodology of classroom 60 ’. Clinical sessions at the health centre for this program of comprehensive training in asthma is based on learning through clinical cases from which taught the theoretical content. Thanks to this project, family physicians can update their knowledge on the diagnosis and classification of asthma, and develop skills in the management of inhalers, as well as in the education of patients. Among the contents that must be addressed are deepen in asthma and COPD, differences in the interpretation of results of pulmonary function tests as the meter of peak flow and spirometry. equally, an update of the clinical practice guidelines will be carried out.

The Spanish Guide of asthma, reference to family physicians

Estimated that up to 60-70% of asthmatics suffer from poor control of disease according to the recommendations of the Global Initiative for Asthma (GINA) or the Spanish Guide for the management of asthma (GEMA), among other reasons for deficiencies in clinical practice of medical personnel.

Currently, the legislation of reference to family physicians is the Spanish Guide for the management of asthma (GEM) which aims to improve the diagnostic and therapeutic action of the professional who treats asthmatic patients in brief, clear and simple. The debate revolves around how to improve the implementation of the recommendations proposed by these guidelines, and in this sense, some methods are very effective as delivery of educational programmes aimed at small groups of professionals and training comprehensive asthma program responds to this fundamental idea., according to says Dr. José Antonio Quintano, Coordinator of the Working Group of SEMERGEN respiratory.

Chiesi Farmaceutici

Laboratories CHIESI is a pharmaceutical multinational with headquarters in Parma (Italy) created more than 75 years ago. In recent years, its policy of promotion of r & d (which devotes 15% of turnover) and the new acquisitions have made it possible that in 2010 it achieved sales exceeding one billion euros. It has three (Italy, France and Brazil) production plants and four research centers in Italy, France, Great Britain and United States. It has a strong presence in Europe (including Spain) and worldwide (United States, Brazil, Mexico, Pakistan, China, Russia, Egypt and the Maghreb countries)